{"DataElement":{"publicId":"7675284","version":"1","preferredName":"Gastrointestinal Stromal Tumor Additional Testing Performed Text","preferredDefinition":"A textual description of the specific tests performed on a gastrointestinal stromal tumor.","longName":"7675282v1.0:6784451v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7675282","version":"1","preferredName":"Gastrointestinal Stromal Tumor Additional Testing Performed","preferredDefinition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases._A question asking if any additional tests were performed during the study.","longName":"2875746v1.0:7063069v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"2875746","version":"1","preferredName":"Gastrointestinal Stromal Tumor","preferredDefinition":"GIST. A type of tumor that usually begins in cells in the wall of the gastrointestinal tract.  It can be benign or malignant.","longName":"C3868","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Stromal Tumor","conceptCode":"C3868","definition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69CC3F8C-54D3-DD89-E040-BB89AD4301CB","latestVersionIndicator":"Yes","beginDate":"2009-05-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-13","modifiedBy":"ONEDATA","dateModified":"2009-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7063069","version":"1","preferredName":"Was Additional Testing Performed","preferredDefinition":"A question asking if any additional tests were performed during the study.","longName":"C157144","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Was Additional Testing Performed","conceptCode":"C157144","definition":"A question asking if any additional tests were performed during the study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"97CC123C-99A3-11CB-E053-F662850A85BC","latestVersionIndicator":"Yes","beginDate":"2019-11-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-20","modifiedBy":"ONEDATA","dateModified":"2019-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C3DCB1F8-A00C-2D11-E053-4EBD850A1CF9","latestVersionIndicator":"Yes","beginDate":"2021-06-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-06-03","modifiedBy":"COLBERTM","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":"6/7/22 mr Released per CPTAC/Nicolletteâ€™s XLS review as part of quarterly metrics review.","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6784451","version":"1","preferredName":"255 Character Text","preferredDefinition":"The words of something written.","longName":"6784451v1.0","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8BA00B33-81DA-0AB8-E053-F662850A521F","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-18","modifiedBy":"KNABLEJ","dateModified":"2020-06-23","changeDescription":"11/10/19 jk Released per CPTAC SME (Linda) for Medical History CRF.  6-18-19 tt created for CPTAC Medical History CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"7218984","version":"1","longName":"Soft Tissue","context":"OCCPR"},{"publicId":"7634335","version":"1","longName":"SAR Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If yes, specify (type and res","type":"Preferred Question Text","description":"If yes, specify (type and result):","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"C3DCB1F8-A054-2D11-E053-4EBD850A1CF9","latestVersionIndicator":"Yes","beginDate":"2021-06-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-06-03","modifiedBy":"COLBERTM","dateModified":"2022-07-11","changeDescription":null,"administrativeNotes":"7/11/22 Updated definition for consistency per spreadsheet from JK. MR","unresolvedIssues":null,"deletedIndicator":"No"}}